[1]
2023. Expression Profiling of HER2 and EGFR in Resected Specimens and Plasma Samples from Patients with Esophageal Adenocarcinoma: A Review. Annals of Gastroenterology and Digestive Disorders. 6, 1 (Aug. 2023), 14–17. DOI:https://doi.org/10.5281/zenodo.22163696.